159 related articles for article (PubMed ID: 26215394)
41. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D
Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639
[TBL] [Abstract][Full Text] [Related]
42. Immune responses in mice vaccinated with a suicidal DNA vaccine expressing the hemagglutinin glycoprotein from the peste des petits ruminants virus.
Wang Y; Liu G; Shi L; Li W; Li C; Chen Z; Jin H; Xu B; Li G
J Virol Methods; 2013 Nov; 193(2):525-30. PubMed ID: 23896018
[TBL] [Abstract][Full Text] [Related]
43. Pseudo-typed Semliki Forest virus delivers EGFP into neurons.
Jia F; Miao H; Zhu X; Xu F
J Neurovirol; 2017 Apr; 23(2):205-215. PubMed ID: 27739033
[TBL] [Abstract][Full Text] [Related]
44. Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus.
Tarbatt CJ; Glasgow GM; Mooney DA; Sheahan BJ; Atkins GJ
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1551-7. PubMed ID: 9225028
[TBL] [Abstract][Full Text] [Related]
45. The effects of oncolytic reovirus in canine lymphoma cell lines.
Hwang CC; Umeki S; Igase M; Coffey M; Noguchi S; Okuda M; Mizuno T
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():61-73. PubMed ID: 25319493
[TBL] [Abstract][Full Text] [Related]
46. Dual specific antitumor effects of Semliki Forest virus-based DNA vector carrying suicide Escherichia coli purine nucleoside phosphorylase gene via Salmonella.
Chen ZH; Huang GL; Tu YQ; Jiang Y; Dai WX
Int J Oncol; 2013 Jun; 42(6):2009-18. PubMed ID: 23588611
[TBL] [Abstract][Full Text] [Related]
47. Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.
van Tiel FH; Harmsen T; Wagenaar M; Boere WA; Kraaijeveld CA; Snippe H
J Clin Microbiol; 1986 Oct; 24(4):665-8. PubMed ID: 3533979
[TBL] [Abstract][Full Text] [Related]
48. Peritoneal barrier to the spread of Semliki forest virus in mice.
Walder CE; Wust CJ; Brown A
Proc Soc Exp Biol Med; 1989 Jan; 190(1):70-8. PubMed ID: 2536182
[TBL] [Abstract][Full Text] [Related]
49. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.
Bird RC; Deinnocentes P; Lenz S; Thacker EE; Curiel DT; Smith BF
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):289-304. PubMed ID: 18423623
[TBL] [Abstract][Full Text] [Related]
50. Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
Petrov I; Gentschev I; Vyalkova A; Elashry MI; Klymiuk MC; Arnhold S; Szalay AA
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664672
[TBL] [Abstract][Full Text] [Related]
51. Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity.
Sarén T; Ramachandran M; Martikainen M; Yu D
Mol Ther Oncolytics; 2017 Dec; 7():67-75. PubMed ID: 29159280
[TBL] [Abstract][Full Text] [Related]
52. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
Crouch CF; Mackenzie A; Dimmock NJ
J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
[TBL] [Abstract][Full Text] [Related]
53. Canine caliciviruses of four serotypes from military and research dogs recovered in 1963-1978 belong to two phylogenetic clades in the Vesivirus genus.
Binn LN; Norby EA; Marchwicki RH; Jarman RG; Keiser PB; Hang J
Virol J; 2018 Feb; 15(1):39. PubMed ID: 29471848
[TBL] [Abstract][Full Text] [Related]
54. Administration with Vaccinia Virus Encoding Canine Parvovirus 2
Zhao W; Wang X; Li Y; Li Y
Viral Immunol; 2020; 33(6):434-443. PubMed ID: 32364832
[TBL] [Abstract][Full Text] [Related]
55. The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice.
Jagelman S; Suckling AJ; Webb HE; Bowen FT
J Gen Virol; 1978 Dec; 41(3):599-607. PubMed ID: 745010
[TBL] [Abstract][Full Text] [Related]
56. Prevalence estimation of tick-borne encephalitis virus (TBEV) antibodies in dogs from Finland using novel dog anti-TBEV IgG MAb-capture and IgG immunofluorescence assays based on recombinant TBEV subviral particles.
Levanov L; Vera CP; Vapalahti O
Ticks Tick Borne Dis; 2016 Jul; 7(5):979-982. PubMed ID: 27189583
[TBL] [Abstract][Full Text] [Related]
57. Abnormalities of responses to autonomic stimulation in the mouse urinary bladder associated with Semliki Forest virus-induced demyelination.
Moss HE; Tansey EM; Burnstock G
J Urol; 1989 Sep; 142(3):850-4. PubMed ID: 2549275
[TBL] [Abstract][Full Text] [Related]
58. Detection by a solid phase independent enzyme immunoassay of monoclonal anti-idiotypic antibodies against monoclonal antibodies neutralizing Semliki Forest virus and encephalomyocarditis virus.
Harmsen M; Oosterlaken TA; Tangerman C; Snippe H; Kraaijeveld CA
J Virol Methods; 1993 Jul; 43(2):137-46. PubMed ID: 8396153
[TBL] [Abstract][Full Text] [Related]
59. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.
Mossman SP; Bex F; Berglund P; Arthos J; O'Neil SP; Riley D; Maul DH; Bruck C; Momin P; Burny A; Fultz PN; Mullins JI; Liljeström P; Hoover EA
J Virol; 1996 Mar; 70(3):1953-60. PubMed ID: 8627721
[TBL] [Abstract][Full Text] [Related]
60. Experimental Hendra virus infection of dogs: virus replication, shedding and potential for transmission.
Middleton DJ; Riddell S; Klein R; Arkinstall R; Haining J; Frazer L; Mottley C; Evans R; Johnson D; Pallister J
Aust Vet J; 2017 Jan; 95(1-2):10-18. PubMed ID: 28124415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
